Restored expression of pep-AP sensitized CRC cells to oxaliplatin treatment by interacting with transaldolase 1 (TALDO1), a key enzyme in the pentose phosphate pathway to inhibit its expression and to attenuate activation of the pentose phosphate pathway [176] (Fig. 3). The gene discussed is TALDO1; the disease is colorectal carcinoma.